Amplifon (AMFPF)
(Delayed Data from OTC)
$32.20 USD
0.00 (0.00%)
Updated Apr 10, 2024 11:39 AM ET
2-Buy of 5 2
C Value B Growth C Momentum B VGM
Income Statements
Fiscal Year end for Amplifon SpA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 2,233 | 2,305 | 1,777 | 1,940 |
Cost Of Goods | NA | 1,686 | 1,751 | 1,353 | 1,525 |
Gross Profit | NA | 547 | 554 | 424 | 415 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 253 | 263 | 231 | 217 |
Income After Depreciation & Amortization | 0 | 294 | 291 | 192 | 198 |
Non-Operating Income | NA | -5 | 6 | -1 | -1 |
Interest Expense | NA | 32 | 33 | 32 | 29 |
Pretax Income | NA | 257 | 264 | 159 | 168 |
Income Taxes | NA | 68 | 71 | 44 | 47 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 188 | 194 | 115 | 122 |
Extras & Discontinued Operations | NA | 0 | -7 | 0 | 0 |
Net Income (GAAP) | NA | 188 | 187 | 115 | 122 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 547 | 554 | 424 | 415 |
Depreciation & Amortization (Cash Flow) | NA | 253 | 263 | 231 | 217 |
Income After Depreciation & Amortization | 0 | 294 | 291 | 192 | 198 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 226.85 | 224.82 | 174.75 | 225.75 |
Diluted EPS Before Non-Recurring Items | NA | 0.85 | 1.10 | 0.66 | 0.69 |
Diluted Net EPS (GAAP) | NA | 0.83 | 0.82 | 0.51 | 0.54 |
Fiscal Year end for Amplifon SpA falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | 578.25 | 624.33 | 579.91 |
Cost Of Goods | NA | NA | NA | NA | 455.78 |
Gross Profit | NA | NA | NA | NA | 124.13 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 66.63 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 57.50 |
Non-Operating Income | NA | NA | NA | NA | -2.93 |
Interest Expense | NA | NA | NA | NA | 9.89 |
Pretax Income | NA | NA | NA | NA | 44.67 |
Income Taxes | NA | NA | NA | NA | 13.27 |
Minority Interest | NA | NA | NA | NA | -0.04 |
Investment Gains/Losses | NA | NA | NA | NA | 0.00 |
Other Income/Charges | NA | NA | NA | NA | 0.00 |
Income From Cont. Operations | NA | NA | 24.00 | 56.67 | 31.41 |
Extras & Discontinued Operations | NA | NA | 0.04 | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | 24.03 | 56.67 | 31.45 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 224.73 | 226.13 | 226.23 |
Diluted EPS Before Non-Recurring Items | NA | NA | 0.16 | 0.26 | 0.17 |
Diluted Net EPS (GAAP) | NA | NA | 0.11 | 0.25 | 0.14 |